Pdt Partners, LLC Repligen Corp Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $208,545 - $333,073	1,300 New	1,300 $243,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $2.52 Million - $4.03 Million	-15,624 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $1.01 Million - $1.24 Million	-4,076 Reduced 20.69%	15,624 $4.14 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.16 Million - $1.93 Million	-5,940 Reduced 23.17%	19,700 $5.69 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $2,322 - $3,093	14 Added 0.05%	25,640 $5.12 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $1.1 Million - $1.37 Million	-6,075 Reduced 19.16%	25,626 $4.98 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $4.32 Million - $6.03 Million	-29,196 Reduced 47.94%	31,701 $6.08 Million
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $468,478 - $605,224	-3,824 Reduced 5.91%	60,897 $8.99 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $640,406 - $953,718	6,789 Added 11.72%	64,721 $8 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $967,184 - $1.24 Million	-11,384 Reduced 16.42%	57,932 $5.59 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $894,645 - $1.13 Million	12,116 Added 21.18%	69,316 $6.41 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $1.88 Million - $2.34 Million	24,500 Added 74.92%	57,200 $4.39 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $471,540 - $747,765	-8,700 Reduced 21.01%	32,700 $2.81 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $1,730 - $2,198	-35 Reduced 0.08%	41,400 $2.45 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $394,187 - $562,611	-8,168 Reduced 16.47%	41,435 $2.19 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $415,162 - $523,122	8,871 Added 21.78%	49,603 $2.75 Million
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $264,026 - $352,235	-7,488 Reduced 15.53%	40,732 $1.92 Million
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $506,067 - $609,998	-16,367 Reduced 25.34%	48,220 $1.75 Million
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $858,369 - $1.03 Million	26,387 Added 69.08%	64,587 $2.34 Million
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $1.41 Million - $1.76 Million	38,200	38,200 $1.46 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.17 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$990 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$781 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$251 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$220 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account